Fig 1.
Scheme to illustrate the blood purification treatments used in the two patient groups.
Patients in the IHD group underwent IHD in combination with hemoperfusion. Hemoperfusion in the IHD group was carried out for 2 h each day, with a blood flow of 150–200 mL/min. IHD was administered for 2 h on day 1, 3 h on day 2, 4 h on day 3, and then 4 h every other day, with a dialysis liquid flow rate of 500 mL/min, and a blood flow of 200–300 mL/min. Patients in the HVHF group underwent HVHF in combination with hemoperfusion (2 h each day, with a blood flow volume of 150–200 mL/min). During the first 72 h of treatment the hemofiltration solution flow rate was 70 mL/kg/h, blood flow was 200–250 mL/min, and the filter and catheter were changed every 24 h; subsequently, hemofiltration solution was given at 70 mL/kg/h for 12 h each day.
Table 1.
Demographic and clinical characteristics of the patients in the HVHF and IHD groups.
Table 2.
Clinical parameters of the patients in the HVHF and IHD groups before and after treatment.
Table 3.
Comparisons of biochemical parameters before and after HVHF.
Table 4.
Comparisons of clinical outcomes at hospital discharge between patients in the HVHF and IHD groups.